Eliptica
Eliptica is a startup headquartered in Newbury, United Kingdom, founded in 2022. It has won about £1.33m in competitive Innovate UK grants since 2023, according to UK Research and Innovation.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Innovation grants
Eliptica has won about £1.33m in competitive Innovate UK grants since 2023.
- AIPIR - Development of an advanced AI proteomic platform to identify, track and predict host response to solid tumour immunotherapies (£664k, 2024)
- DCAD - Developing better diagnostics for Coronary Artery Disease with novel AI-enhanced, ultra fast proteomics (£664k, 2023)
R&D ecosystem
Eliptica sits inside the London and the Golden Triangle R&D ecosystem in the Global R&D Labs Directory.
Related
Questions and answers
What does Eliptica do?
Eliptica works in biotechnology. Its Innovate UK projects include: AIPIR - Development of an advanced AI proteomic platform to identify, track and predict host response to solid tumour immunotherapies.
Where is Eliptica based?
Eliptica is headquartered in Newbury, United Kingdom.
When was Eliptica founded?
Eliptica was founded in 2022.
Source records: Companies House and UK Research and Innovation.
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.